Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer. - Modi, S.; Jacot, W.; Yamashita, T.; Sohn, J.; Vidal, M.; Tokunaga, E.; Tsurutani, J.; Ueno, N. T.; Prat, A.; Chae, Y. S.; Lee, K. S.; Niikura, N.; et al. (New England Journal of Medicine, 2022)